Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM32G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,543
Award facts
- Contract value 100% obligated
- $52,543.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $52,543.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of December 31, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's corporate office, with performance executed from the company's Conshohocken, Pennsylvania headquarters. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to provide a broad portfolio of medications and medical supplies to support military healthcare operations globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, continues to serve as a primary supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this strategic contract vehicle. The Dupixent delivery order represents a component of the company's extensive federal pharmaceutical supply operations, which encompass specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. DLA's approach of establishing multiple regional pharmaceutical prime vendor contracts under its Generation V program ensures AmerisourceBergen's continued participation in the military's medical supply chain alongside other qualified contractors.
Quick answers
Who was awarded contract SPE2DR26FM32G?
SPE2DR26FM32G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FM32G worth?
The government has obligated $52,543 on SPE2DR26FM32G.
Is contract SPE2DR26FM32G an order under another contract?
Yes. SPE2DR26FM32G is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM32G competed?
The extent of competition for SPE2DR26FM32G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award